Jason M God
Overview
Explore the profile of Jason M God including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson B, Radwan F, Hossain A, Doonan B, Hathaway-Schrader J, God J, et al.
J Cell Biochem
. 2018 Nov;
120(4):6264-6276.
PMID: 30378157
Though the current therapies are effective at clearing an early stage prostate cancer, they often fail to treat late-stage metastatic disease. We aimed to investigate the molecular mechanisms underlying the...
2.
3.
God J, Cameron C, Figueroa J, Amria S, Hossain A, Kempkes B, et al.
J Immunol
. 2015 Jan;
194(4):1434-45.
PMID: 25595783
Elevated levels of the transcription factor c-myc are strongly associated with various cancers, and in particular B cell lymphomas. Although many of c-MYC's functions have been elucidated, its effect on...
4.
Radwan F, Hossain A, God J, Leaphart N, Elvington M, Nagarkatti M, et al.
J Cell Biochem
. 2014 Aug;
116(1):102-14.
PMID: 25142864
Lymphoma is a potentially life threatening disease. The goal of this study was to investigate the therapeutic potential of a natural triterpenoid, Ganoderic acid A (GA-A) in controlling lymphoma growth...
5.
God J, Zhao D, Cameron C, Amria S, Bethard J, Haque A
Immunology
. 2014 Mar;
142(3):492-505.
PMID: 24628049
While Burkitt lymphoma (BL) has a well-known defect in HLA class I-mediated antigen presentation, the exact role of BL-associated HLA class II in generating a poor CD4(+) T-cell response remains...
6.
7.
Hossain A, Radwan F, Doonan B, God J, Zhang L, Bell P, et al.
Apoptosis
. 2012 Aug;
17(10):1066-78.
PMID: 22847295
Melanoma is the most aggressive form of skin cancer, responsible for the majority of skin cancer related deaths. Thus, the search for natural molecules which can effectively destroy tumors while...
8.
Hossain A, God J, Radwan F, Amria S, Zhao D, Bethard J, et al.
Clin Dev Immunol
. 2011 Dec;
2011:780839.
PMID: 22162713
While the defects in HLA class I-mediated Ag presentation by Burkitt lymphoma (BL) have been well documented, CD4+ T-cells are also poorly stimulated by HLA class II Ag presentation, and...
9.
Radwan F, Zhang L, Hossain A, Doonan B, God J, Haque A
Leuk Lymphoma
. 2011 Aug;
53(2):305-14.
PMID: 21854084
Malignant B-cells express measurable levels of human leukocyte antigen (HLA) class II proteins, but often escape immune recognition by CD4 + T cells. Resveratrol (Resv) has been the focus of...
10.
God J, Haque A
J Oncol
. 2010 Oct;
2010.
PMID: 20953370
B-cell lymphomas arise at distinct stages of cellular development and maturation, potentially influencing antigen (Ag) presentation and T-cell recognition. Burkitt lymphoma (BL) is a highly malignant B-cell tumor associated with...